Significantly diminished lead PAD-induced propidium iodide and/or annexin-V incorporation were observed in cells pre-treated with Z-VAD-FMK compared to those pre-treated with either DMSO or a control inhibitor Z-FA-FMK, implying caspase activation following drug administration. This evidence concerns the gene ANXA5 and peripheral arterial disease.